ZetaGen Therapeutics logo

ZetaGen Therapeutics Funding & Investors

Syracuse, NY

ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway.Discovered serendipitously, ZetaGen's products have the potential to transform the treatment of bone-related injuries, procedures,... Read more

zetagen.com

Total Amount Raised: $14,356,000

ZetaGen Therapeutics Funding Rounds

  • Series B

    $9,790,000

    Series B Investors

    Consolidated Investment Group
    New York Ventures

  • Grant

    $2,000,000

    Grant Investors

    National Cancer Institute (NCI)

  • Seed

    $840,000

  • Seed

    $1,726,000

Funding info provided by Diffbot.